HCA Healthcare, Inc. (NYSE:HCA) Shares Sold by CFM Wealth Partners LLC

CFM Wealth Partners LLC decreased its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 4.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,931 shares of the company’s stock after selling 97 shares during the quarter. CFM Wealth Partners LLC’s holdings in HCA Healthcare were worth $580,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of the company. FMR LLC boosted its holdings in shares of HCA Healthcare by 322.3% in the third quarter. FMR LLC now owns 3,141,769 shares of the company’s stock valued at $1,276,909,000 after acquiring an additional 2,397,883 shares in the last quarter. Franklin Resources Inc. lifted its holdings in shares of HCA Healthcare by 11.7% during the 3rd quarter. Franklin Resources Inc. now owns 1,669,721 shares of the company’s stock worth $660,842,000 after acquiring an additional 174,946 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in HCA Healthcare by 2.8% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,487,367 shares of the company’s stock valued at $604,511,000 after purchasing an additional 41,190 shares during the last quarter. Janus Henderson Group PLC raised its stake in shares of HCA Healthcare by 12.0% in the third quarter. Janus Henderson Group PLC now owns 1,339,638 shares of the company’s stock worth $544,467,000 after acquiring an additional 143,995 shares during the last quarter. Finally, Nordea Investment Management AB grew its holdings in HCA Healthcare by 29.7% during the fourth quarter. Nordea Investment Management AB now owns 843,764 shares of the company’s stock valued at $253,020,000 after purchasing an additional 193,075 shares during the period. Institutional investors own 62.73% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on the stock. Cantor Fitzgerald restated an “overweight” rating and issued a $405.00 price target on shares of HCA Healthcare in a research note on Monday, January 27th. Wells Fargo & Company downgraded shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and reduced their price objective for the stock from $400.00 to $320.00 in a research report on Monday, November 25th. TD Cowen dropped their price objective on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a research note on Monday, October 28th. Royal Bank of Canada lowered their price objective on HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating on the stock in a research note on Monday, January 27th. Finally, Morgan Stanley decreased their price objective on shares of HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a research report on Tuesday, December 17th. One analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $385.67.

Insider Activity at HCA Healthcare

In other HCA Healthcare news, insider Erol R. Akdamar sold 2,900 shares of the business’s stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the sale, the insider now directly owns 6,843 shares of the company’s stock, valued at $2,415,579. The trade was a 29.76 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Phillip G. Billington sold 3,897 shares of the business’s stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the transaction, the senior vice president now owns 52,702 shares in the company, valued at approximately $18,445,700. This represents a 6.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.70% of the stock is owned by corporate insiders.

HCA Healthcare Stock Down 1.3 %

HCA Healthcare stock opened at $330.24 on Monday. The company has a market capitalization of $83.65 billion, a P/E ratio of 15.03, a PEG ratio of 1.13 and a beta of 1.64. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $417.14. The stock has a 50-day simple moving average of $313.33 and a 200-day simple moving average of $353.29. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, topping analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same period in the previous year, the company posted $5.90 EPS. Equities research analysts expect that HCA Healthcare, Inc. will post 24.89 earnings per share for the current year.

HCA Healthcare Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Monday, March 17th will be issued a $0.72 dividend. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. This represents a $2.88 annualized dividend and a yield of 0.87%. The ex-dividend date is Monday, March 17th. HCA Healthcare’s payout ratio is currently 12.02%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.